HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric C LaCasse Selected Research

DNA (Deoxyribonucleic Acid)

3/2007Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric C LaCasse Research Topics

Disease

14Neoplasms (Cancer)
01/2023 - 07/2003
3Glioblastoma (Glioblastoma Multiforme)
01/2018 - 03/2007
1Venous Thromboembolism
01/2023
1Inflammation (Inflammations)
01/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1Pulmonary Embolism
01/2023
1Atrophy
01/2019
1Cachexia
01/2019
1Muscular Atrophy (Muscle Atrophy)
01/2019
1Vesicular Stomatitis
09/2018
1Necrosis
01/2017
1Cytokine Release Syndrome
02/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2013
1Lymphoma (Lymphomas)
05/2013
1Carcinogenesis
09/2007
1Neuroblastoma
03/2007
1Carcinoma (Carcinomatosis)
03/2007
1Leukemia
09/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2003
1Lung Neoplasms (Lung Cancer)
07/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2006
3CytokinesIBA
01/2023 - 02/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2018 - 09/2006
3Antisense OligonucleotidesIBA
05/2013 - 07/2003
2LCL161IBA
01/2023 - 09/2018
2Inhibitor of Apoptosis ProteinsIBA
01/2019 - 09/2018
2CaspasesIBA
01/2019 - 03/2007
2Small Interfering RNA (siRNA)IBA
01/2019 - 01/2019
2LigandsIBA
09/2018 - 09/2006
2Immune Checkpoint InhibitorsIBA
01/2018 - 01/2017
2InterferonsIBA
01/2017 - 03/2007
2AEG 35156IBA
05/2013 - 09/2006
2X-Linked Inhibitor of Apoptosis ProteinIBA
09/2006 - 07/2003
1AntigensIBA
01/2023
1Janus Kinase InhibitorsIBA
01/2023
1tofacitinibIBA
01/2023
1Janus KinasesIBA
01/2023
1NF-kappa B (NF-kB)IBA
01/2019
1Sp3 Transcription FactorIBA
01/2019
1Ligases (Synthetase)IBA
01/2019
1UbiquitinIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1Interferon Type IIBA
09/2018
1Poly I-CIBA
02/2014
1TNF-Related Apoptosis-Inducing LigandIBA
02/2014
1Interferon-betaIBA
02/2014
1hydrogen sulfite (bisulfite)IBA
03/2007
1DNA (Deoxyribonucleic Acid)IBA
03/2007
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2006
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
09/2006
1OligonucleotidesIBA
09/2006
1Taxoids (Taxanes)IBA
09/2006
1Docetaxel (Taxotere)FDA Link
09/2006
1Messenger RNA (mRNA)IBA
09/2006
1Vinorelbine (Navelbine)FDA LinkGeneric
07/2003

Therapy/Procedure

5Therapeutics
01/2017 - 07/2003
2Immunotherapy
09/2018 - 01/2014
2Drug Therapy (Chemotherapy)
09/2006 - 07/2003
1Denervation
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
05/2013
1Radiotherapy
09/2007